Project Summary
Flow cytometry is a specialized technology that characterizes cells on a single-cell basis and is heavily used in
the fields of immunology, infectious diseases and cancer biology. As flow cytometry technology has advanced,
the multiplexing capability has markedly expanded allowing for more markers to be examined simultaneously.
These advances have increased the complexity of experimental design of and of the expertise required to
appropriately analyze and detect potential artifacts hidden in the resulting data. Advanced training is critical to
appropriately implement these technologies in resource-limited settings where exposure to scientists and
mentors with the requisite expertise is limited. Although complete mastery can take years, the practical as well
as the theoretical tools needed to achieve competency can be taught in a relatively short workshop.
The African Flow Cytometry Workshop has been held biennially since 2005 in Cape Town, South Africa with the
aim of enhancing both the theoretical and technical flow cytometry knowledge of African immunologists so that
this cutting-edge technology can be applied to critical studies being conducted on the continent. This technology
has unique capabilities to help address scientific questions of particular relevance in Africa given the high
prevalence of disease caused by the three major global pathogens, HIV, tuberculosis and malaria. As flow
cytometry instruments with greater capabilities have become more available in Africa, the number of scientists
needing this advanced knowledge has also increased. Training opportunities that exist for African investigators
remain very limited and can be very costly.
The African Flow Cytometry Workshop is structured over five full days and consists of a combination of lectures
and hands-on tutorials with homework assigned each evening and an initial and final exam. Participant numbers
are limited to 20, to ensure appropriate interaction between faculty and students and to facilitate peer-to-peer
interactions. We have conducted nine previous workshops and this experience has demonstrated the need for
this type of training and has shown successful outcomes for many prior participants (Nemes et al, 2016). As in
prior workshops, the selection process is conducted in a thoughtful way in order to choose participants across
geographic regions in Africa who are likely to apply their training and train others in their home laboratory or
institution. In fact, a survey of prior workshop participants demonstrated that almost 90% of our survey
respondents reported having trained peers at their home institution after the workshop, often by adapting
teaching materials provided by the workshop. In an effort to perpetuate the training, we have incorporated a
strategy to invite and select high-achieving past participants to join the workshop faculty, which has served to
deepen their understanding of flow cytometry and provide them with leadership training. The workshop training
is therefore maximized through a “train the trainer” model and through the development of a specialized network
of African flow cytometry experts in the field of infectious disease.
Public Health Relevance Statement
Project Narrative
Africa is particularly burdened by major infectious diseases, including HIV, tuberculosis and malaria, and
research into the immunology of these diseases that can impact diagnosis, treatment and prevention is enabled
by flow cytometry, most notably the more advanced technologies that now allow for highly multiplexed marker
detection at the single-cell level. There is an ongoing need to improve and further develop the flow cytometry
skills of infectious disease researchers in Africa to ensure the highest quality research is being conducted. The
purpose of the African Flow Cytometry Workshop is to enhance both the theoretical and the technical knowledge
of African immunologists, to establish connections with experts among the workshop faculty and to strengthen
the collaborative peer scientific network within Africa.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
806433145
UEI
TJFZLPP6NYL6
Project Start Date
01-December-2024
Project End Date
30-November-2029
Budget Start Date
01-December-2024
Budget End Date
30-November-2025
Project Funding Information for 2025
Total Funding
$25,000
Direct Costs
$25,000
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2025
National Institute of Allergy and Infectious Diseases
$25,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R13AI189265-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R13AI189265-01
Patents
No Patents information available for 1R13AI189265-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R13AI189265-01
Clinical Studies
No Clinical Studies information available for 1R13AI189265-01
News and More
Related News Releases
No news release information available for 1R13AI189265-01
History
No Historical information available for 1R13AI189265-01
Similar Projects
No Similar Projects information available for 1R13AI189265-01